Suven Pharmaceuticals Ltd
NSE:SUVENPHAR

Watchlist Manager
Suven Pharmaceuticals Ltd Logo
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Watchlist
Price: 1 097 INR 3.12% Market Closed
Market Cap: 419.7B INR

Wall Street
Price Targets

SUVENPHAR Price Targets Summary
Suven Pharmaceuticals Ltd

There are no price targets for SUVENPHAR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Suven Pharmaceuticals Ltd Competitors:
Price Targets
TARS
Tarsus Pharmaceuticals Inc
13% Upside
SUPN
Supernus Pharmaceuticals Inc
22% Upside
4507
Shionogi & Co Ltd
6% Downside
NEULANDLAB
Neuland Laboratories Ltd
47% Upside
4503
Astellas Pharma Inc
14% Downside
300723
Yipinhong Pharmaceutical Co Ltd
22% Upside
AHEALTH
Apex Healthcare Bhd
11% Downside
STAR
Strides Pharma Science Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Suven Pharmaceuticals Ltd

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 4 years is 46%.

6%
Past Growth
46%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Suven Pharmaceuticals Ltd

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's operating income is 0%. The projected CAGR for the next 4 years is 44%.

0%
Past Growth
44%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Suven Pharmaceuticals Ltd

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's net income is -1%. The projected CAGR for the next 4 years is 40%.

-1%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUVENPHAR's stock price target?
Not Available

SUVENPHAR doesn't have any price targets made by Wall Street professionals.

What is Suven Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
46%

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 4 years is 46%.

What is Suven Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
44%

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's operating income is 0%. The projected CAGR for the next 4 years is 44%.

What is Suven Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
40%

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's net income is -1%. The projected CAGR for the next 4 years is 40%.

Back to Top